616 related articles for article (PubMed ID: 2507568)
1. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
[TBL] [Abstract][Full Text] [Related]
2. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
3. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
5. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
6. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
le Nestour E; Marraoui J; Lahlou N; Roger M; de Ziegler D; Bouchard P
J Clin Endocrinol Metab; 1993 Aug; 77(2):439-42. PubMed ID: 8345049
[TBL] [Abstract][Full Text] [Related]
7. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
MacNaughton J; Banah M; McCloud P; Hee J; Burger H
Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
Hall JE; Schoenfeld DA; Martin KA; Crowley WF
J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
[TBL] [Abstract][Full Text] [Related]
9. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
[TBL] [Abstract][Full Text] [Related]
10. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
11. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids.
Burger HG; Hee JP; Mamers P; Bangah M; Zissimos M; McCloud PI
Clin Endocrinol (Oxf); 1994 Dec; 41(6):771-7. PubMed ID: 7889613
[TBL] [Abstract][Full Text] [Related]
14. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
16. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
17. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
[TBL] [Abstract][Full Text] [Related]
19. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
20. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
